Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

The Effects of Nitric Oxide Donors on Uterine Artery and Sub-endometrial Blood Flow in Patients with Unexplained Recurrent Abortion

Authors
Department of Obstetrics and Gynecology, Benha Faculty of Medicine, Benha, Qalyubia, Egypt
Abstract
Background: Nitric oxide plays a major role in increasing uterine blood flow during the luteal phase and early pregnancy. This study was done to compare uterine artery and sub-endometrial blood flow indices during the luteal phase between patients with unexplained recurrent abortion and fertile women and also to evaluate the effects of nitric oxide donors on blood flow indices in the abortion group. Methods: The study included a control group of 30 primiparae who had normal vaginal delivery and no history of abortion and an abortion group of 30 nulliparous women with history of two or more unexplained recurrent abortions. Transvaginal three-dimensional pulsed color Doppler ultrasound was done on days 21-23 of the cycle to measure uterine artery resistance and pulsation indices and the subendometrial vascular, flow and vascular-flow indices. Isosorbide mononitrate 20 mg tablet was administered vaginally in the abortion group and blood flow indices were measured again after two hours. The Student t-test and the paired t-test were used for analysis of results and a p-value of ≤0.05 was considered significant. Results: Patients with unexplained recurrent abortion had significantly higher uterine artery resistance and pulsation indices and lower sub-endometrial vascular, flow and vascular-flow index (p<0.01-0.0001). Isosorbide mononitrite significantly decreased uterine artery and increased sub-endometrial blood flow indices (p<0.001). Conclusion: Uterine artery and sub-endometrial blood flow decreased during the luteal phase in patients with unexplained recurrent abortion. Nitric oxide donors increased blood flow and may be of a therapeutic value.
Keywords

  1. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21(9):2216-22.
  2. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008;89(6):1603.
  3. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368(9535):601-11.
  4. Tzioras S, Polyzos NP, Economides DL. How do you solve the problem of recurrent miscarriage? Reprod Biomed Online. 2009;19(3):296-7.
  5. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update. 2002;8(5):463-81.
  6. Bernstein IM, Ziegler WF, Leavitt T, Badger GJ. Uterine artery hemodynamic adaptations through the menstrual cycle into early pregnancy. Obstet Gynecol. 2002;99(4):620-4.
  7. Detti L, Johnson SC, Diamond MP, Puscheck EE. First-trimester Doppler investigation of the uterine circulation. Am J Obstet Gynecol. 2006;195(5):1210-8.
  8. Gunzel-Apel AR, Hoftmann T, Nottorf S, Politt E, Meyer-Lindenberg A, Hoppen HO, et al. Influence of progesterone withdrawal on pregnancy-related parameters during post-implantation early pregnancy loss. Reprod Domest Anim. 2009;44 Suppl 2:174-81.
  9. Alexander BT, Llinas MT, Kruckeberg WC, Granger JP. L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension. 2004;43(4):832-6.
  10. Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol. 2009;7:79.
  11. El-Far M, El-Motwally Ael-G, Hashem IA, Bakry N. Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt. Clin Chem Lab Med. 2009;47(11):1433-8.
  12. Amin AF, Shaaban OM, Bediawy MA. N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reprod Biomed Online. 2008;17(5):722-6.
  13. Amit A, Thaler I, Paz Y, Itskovitz-Eldor J. The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy. Ultrasound Obstet Gynecol. 1998;11(2):94-8.
  14. Jirous J, Diejomaoh ME, Al-Abdulhadi F, Boland MH, Nazar M. A comparison of the uterine and intraovarian arterial flows in nonpregnant women having a history of recurrent spontaneous miscarriage associated with antiphospholipid syndrome. Arch Gynecol Obstet. 2004;270(2):74-8.
  15. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod. 2002;17(1):190-4.
  16. Ferreira AM, Pires CR, Moron AF, Araujo Júnior E, Traina E, Mattar R. Doppler assessment of uterine blood flow in recurrent pregnancy loss. Int J Gynaecol Obstet. 2007;98(2):115-9.
  17. Vaquero E, Lazzarine N, Exacoustos C, Romanini E, Bertonotti E. Recurrent miscarriage: three dimentional power Doppler evaluation of endometrial and subendometrial volume and vascularity and correlation to uterine arteries blood flow. Ultrasound Obstet Gynecol. 2008;32:262-6.doi: 10.1002/uog.5467/full
  18. Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Endometrial and subendometrial vascularity is higher in pregnant patients with livebirth following ART than in those who suffer a miscarriage. Hum Reprod. 2007;22(4):1134-41.
  19. Zaidi J, Campbell S, Pittrof R, Tan SL. Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in vitro fertilization program. Ultrasound Obstet Gynecol. 1995;6(3):191-8.
  20. Chien LW, Au HK, Chen PL, Xiao J, Tzeng CR. Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2002;78(2):245-51.
  21. El-mashad AI, Mohamed MA, Farag MA, Ahmad MK, Ismail Y. Role of uterine artery Doppler velocimetry indices and plasma adrenomedullin level in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol Res. 2011;37(1):51-7.
  22. Yildiz G, Yavuzcan A, Yildiz P, Goynumer G, Yucel N. Effect of uterine artery blood flow on recurrent pregnancy loss. Clin Exp Obstet Gynecol. 2012;39(3):326-9.
  23. Hale SA, Jones CW, Osol G, Schonberg A, Badger GJ, Bernstein IM. Sildenafil increases uterine blood flow in nonpregnant nulliparous women. Reprod Sci. 2010;17(4):358-65.
  24. Kublickiene KR, Nisell H, Poston L, Kruger K, Lindblom B. Modulation of vascular tone by nitric oxide and endothelin 1 in myometrial resistance arteries from pregnant women at term. Am J Obstet Gynecol. 2000;182(1 Pt 1):87-93.
  25. Storment JM, Meyer M, Osol G. Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat. Am J Obstet Gynecol. 2000;183(2):449-53.
  26. Moncada S. The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand. 1992;145(3):201-27.
  27. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol. 1993;150(11):5080-5.
  28. Longo M, Jain V, Vedernikov YP, Saade GR, Goodrum L, Facchinetti F, et al. Effect of nitric oxide and carbon monoxide on uterine contractility during human and rat pregnancy. Am J Obstet Gynecol. 1999;181(4):981-8.